Senate Bill 2208
115th Congress(2017-2018)
A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.
Introduced
Introduced in Senate on Dec 7, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2208
Congress
115
Policy Area
Government Operations and Politics
Government Operations and Politics
Primary focus of measure is government administration, including agency organization, contracting, facilities and property, information management and services; rulemaking and administrative law; elections and political activities; government employees and officials; Presidents; ethics and public participation; postal service. Measures concerning agency appropriations and the budget process may fall under Economics and Public Finance policy area.
No Senate votes have been held for this bill.
Summary
This bill directs the U.S. Postal Service to issue and sell an Alzheimer's Disease Research Semipostal Stamp.
Proceeds from the sale of the stamp must be transferred to the National Institutes of Health for medical research relating to Alzheimer's disease.
The stamp must be made available to the public for six years.
Any limitation relating to whether more than one semipostal stamp may be offered for sale at the same time shall not apply to the stamp issued under this bill.
December 7, 2017
12/07/2017
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
12/07/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:39:08 PM